Regulation of the plasminogen activator inhibitor-2 (PAI-2) gene in murine macrophages. Demonstration of a novel pattern of responsiveness to bacterial endotoxin

被引:42
作者
Costelloe, EO
Stacey, KJ
Antalis, TM
Hume, DA [1 ]
机构
[1] Univ Queensland, Dept Microbiol, St Lucia, Qld 4072, Australia
[2] Univ Queensland, Dept Biochem, St Lucia, Qld 4072, Australia
[3] Univ Queensland, Ctr Cellular & Mol Biol, St Lucia, Qld 4072, Australia
[4] Queensland Inst Med Res, Herston, Qld 4006, Australia
关键词
serpin; lipopolysaccharide; septicemia; uPA; colony-stimulating factor-1; tumor necrosis factor alpha; inducible nitric oxide synthase;
D O I
10.1002/jlb.66.1.172
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We investigate the regulation of plasminogen activator inhibitor-2 (PAI-2) inn murine macrophages. PAI-2 mRNA Tvas inducible By bacterial lipopolysaccharide (LPS) in primary cells and macrophage-like cell Lines. Evidence is presented for a role for autocrine factors, including cyclooxygenase products but not the cytokines tumor necrosis factor alpha or interferon-beta (IFN-beta), PAI-2 mRNA levels generally varied inversely front those of its target, urokinase-type plasminogen activator (uPA), and the macrophage growth factor CSF-1, which induces uPA, inhibited PAI-2 expression hn cells treated subsequently with LPS. Expression of PAI-2 Tvas distinct from that of other LPS-inducible genes in terms of induction time course, LPS dose response, and sensitivity to co-stimulation with IFN-gamma, induction of PAI-2 mRNA in subclones of the cell hue RAW 264 was not uniform, reflecting heterogeneous expression in the parent line. The expression pattern of PAI-2 is discussed inn terms of a possible role in LPS-induced pathology such as septicemia.
引用
收藏
页码:172 / 182
页数:11
相关论文
共 51 条
[1]  
ALLEY EW, 1994, J ENDOTOXIN RES, V1, P235
[2]  
Amura CR, 1998, J IMMUNOL, V161, P2552
[3]   CONTROL OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 GENE-EXPRESSION IN THE DIFFERENTIATION OF MONOCYTIC CELLS [J].
ANTALIS, TM ;
DICKINSON, JL .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 205 (01) :203-209
[4]   The serine proteinase inhibitor (Serpin) plasminogen activation inhibitor type 2 protects against viral cytopathic effects by constitutive interferon α/β priming [J].
Antalis, TM ;
La Linn, M ;
Donnan, K ;
Mateo, L ;
Gardner, J ;
Dickinson, JL ;
Buttigieg, K ;
Suhrbier, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) :1799-1811
[5]  
BACHMANN F, 1995, THROMB HAEMOSTASIS, V74, P172
[6]   CLONING, NUCLEOTIDE SEQUENCING AND EXPRESSION OF CDNAS ENCODING MOUSE UROKINASE-TYPE PLASMINOGEN-ACTIVATOR [J].
BELIN, D ;
VASSALLI, JD ;
COMBEPINE, C ;
GODEAU, F ;
NAGAMINE, Y ;
REICH, E ;
KOCHER, HP ;
DUVOISIN, RM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 148 (02) :225-232
[7]   IDENTIFICATION OF A COMMON NUCLEOTIDE-SEQUENCE IN THE 3'-UNTRANSLATED REGION OF MESSENGER-RNA MOLECULES SPECIFYING INFLAMMATORY MEDIATORS [J].
CAPUT, D ;
BEUTLER, B ;
HARTOG, K ;
THAYER, R ;
BROWNSHIMER, S ;
CERAMI, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) :1670-1674
[8]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[9]  
CHANG S, IN PRESS J LEUKOC BI
[10]   MACROPHAGE FIBRINOLYTIC-ACTIVITY - IDENTIFICATION OF 2 PATHWAYS OF PLASMIN FORMATION BY INTACT-CELLS AND OF A PLASMINOGEN-ACTIVATOR INHIBITOR [J].
CHAPMAN, HA ;
VAVRIN, Z ;
HIBBS, JB .
CELL, 1982, 28 (03) :653-662